-- Provides additional operational and financial flexibility --
-- Underscores strength of forecasted earnings and operating cash flow --
Read more at globenewswire.comPacira BioSciences Announces Closing of $375 Million Five-Year Term Loan B
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.
